Skip to main content

Among the challenges are moments of joy.

The federal government is committed to making every day better for people with dementia, their caregivers, and their families.

 

Find out how we’re taking action.

Why Participate in a Clinical Trial?

When you volunteer for a clinical trial, you help bring us closer to Alzheimer’s treatment and prevention discoveries.

News & Events

scientific image of stem cells
New web portal gives scientists access to dozens of neurodegenerative disease stem cells
Researchers can obtain stem cells that NIH Center for Alzheimer’s and Related Dementias (CARD) scientists have specially engineered for studying the genes behind Alzheimer’s disease several other neurodegenerative disorders.
NIH Professional Judgement Budget for Alzheimer's Disease and Related Dementias Research, Fiscal Year 2024. Looking Forward: Opportunities to Accelerate Alzheimer's and Related Dementias Research: Innovations in Prevention, Treatment, and Care Research
NIH Alzheimer’s Disease and Related Dementias Professional Judgment Budget for FY2024 now online
During the July 25 meeting of the Advisory Council on Alzheimer’s Research, Care, and Services, NIA Director Richard J. Hodes, M.D., unveiled NIH’s FY 2024 Professional Judgment Budget for Alzheimer’s Disease and Related Dementias. 
microscopic graphic of cerebral spinal fluid flowing through the vasculature of a young mouse
Cerebrospinal fluid from young mice improved memory in older mice
Scientists discovered a specific protein in young mice CSF that may help improve memory and provide a new therapeutic target for treating age-related memory loss and neurodegenerative disorders.